Urine has become one of the most attractive biofluids in clinical proteomics,for its procurement is easy and noninvasive and it contains sufficient proteins and peptides. Urinary proteomics has thus rapidly developed ...Urine has become one of the most attractive biofluids in clinical proteomics,for its procurement is easy and noninvasive and it contains sufficient proteins and peptides. Urinary proteomics has thus rapidly developed and has been extensively applied to biomarker discovery in clinical diseases,especially kidney diseases. In this review,we discuss two important aspects of urinary proteomics in detail,namely,sample preparation and proteomic tech-nologies. In addition,data mining in urinary proteomics is also briefly introduced. At last,we present several successful examples on the application of urinary proteomics for biomarker discovery in kidney diseases,including diabetic nephropathy,IgA nephropathy,lupus nephritis,renal Fanconi syndrome,acute kidney injury,and renal allograft rejection.展开更多
基金Project supported by the National Natural Science Foundation of China (No. 30500598)the Medical Health Science Research Foundation of Zhejiang Province, China (No. 2007B102)
文摘Urine has become one of the most attractive biofluids in clinical proteomics,for its procurement is easy and noninvasive and it contains sufficient proteins and peptides. Urinary proteomics has thus rapidly developed and has been extensively applied to biomarker discovery in clinical diseases,especially kidney diseases. In this review,we discuss two important aspects of urinary proteomics in detail,namely,sample preparation and proteomic tech-nologies. In addition,data mining in urinary proteomics is also briefly introduced. At last,we present several successful examples on the application of urinary proteomics for biomarker discovery in kidney diseases,including diabetic nephropathy,IgA nephropathy,lupus nephritis,renal Fanconi syndrome,acute kidney injury,and renal allograft rejection.
